Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hirsch

Showing results (41-50 of 339) with videos related to

Pageof 34
Sort By:
Vox Sanguinis|March 1, 1981
Requirements of automation of record-keeping and blood distribution systemsR L Hirsch, P Cazal
Journal of Abnormal Psychology|December 1, 1977
Associative interference and premorbid adjustment in schizophreniaC L Hirsch, A S DeWolfe
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1979
The pathogenesis of Sindbis virus infection in athymic nude miceR L Hirsch, D E Griffin
Emergency Medicine Journal : EMJ|September 5, 2003
Entry overload, emergency department overcrowding, and ambulance bypassD M Fatovich, R L Hirsch
Current Gene Therapy|June 10, 2016
AAV Vectorization of DSB-mediated Gene Editing TechnologiesRachel J Moser, Matthew L Hirsch
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2014
AAV-mediated gene editing via double-strand break repairMatthew L Hirsch, R Jude Samulski
International Journal of Molecular Sciences|April 12, 2022
Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the EyeBrian C Gilger, Matthew L Hirsch
Neurosurgery Clinics of North America|June 7, 2008
Imaging of acoustic neuromas. 1992Hugh D Curtin, William L Hirsch
Clinical Immunology and Immunopathology|November 1, 1985
Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2R L Hirsch, K P Johnson
Neurology|April 1, 1985
The effect of recombinant alpha 2-interferon on defective natural killer cell activity in multiple sclerosisR L Hirsch, K P Johnson
Pageof 34

Showing results (41-50 of 339) with videos related to

Sort By:
Pageof 34
Vox Sanguinis|March 1, 1981
Requirements of automation of record-keeping and blood distribution systemsR L Hirsch, P Cazal
Journal of Abnormal Psychology|December 1, 1977
Associative interference and premorbid adjustment in schizophreniaC L Hirsch, A S DeWolfe
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1979
The pathogenesis of Sindbis virus infection in athymic nude miceR L Hirsch, D E Griffin
Emergency Medicine Journal : EMJ|September 5, 2003
Entry overload, emergency department overcrowding, and ambulance bypassD M Fatovich, R L Hirsch
Current Gene Therapy|June 10, 2016
AAV Vectorization of DSB-mediated Gene Editing TechnologiesRachel J Moser, Matthew L Hirsch
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2014
AAV-mediated gene editing via double-strand break repairMatthew L Hirsch, R Jude Samulski
International Journal of Molecular Sciences|April 12, 2022
Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the EyeBrian C Gilger, Matthew L Hirsch
Neurosurgery Clinics of North America|June 7, 2008
Imaging of acoustic neuromas. 1992Hugh D Curtin, William L Hirsch
Clinical Immunology and Immunopathology|November 1, 1985
Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-alpha 2R L Hirsch, K P Johnson
Neurology|April 1, 1985
The effect of recombinant alpha 2-interferon on defective natural killer cell activity in multiple sclerosisR L Hirsch, K P Johnson
Pageof 34